David Ketteridge

2.0k total citations
31 papers, 1.1k citations indexed

About

David Ketteridge is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, David Ketteridge has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 13 papers in Epidemiology and 12 papers in Rheumatology. Recurrent topics in David Ketteridge's work include Lysosomal Storage Disorders Research (18 papers), Trypanosoma species research and implications (13 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). David Ketteridge is often cited by papers focused on Lysosomal Storage Disorders Research (18 papers), Trypanosoma species research and implications (13 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). David Ketteridge collaborates with scholars based in Australia, United States and United Kingdom. David Ketteridge's co-authors include Paul Harmatz, Elisa Leão Teles, Roberto Giugliani, John J. Hopwood, Clara Sá-Miranda, Stuart J. Swiedler, Nathalie Guffon, Michael Beck, Zi‐Fan Yu and Ida Vanessa Döederlein Schwartz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Human Mutation.

In The Last Decade

David Ketteridge

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ketteridge Australia 15 739 511 263 239 131 31 1.1k
Maira Graeff Burin Brazil 21 918 1.2× 388 0.8× 206 0.8× 239 1.0× 43 0.3× 65 1.1k
C. Ronald Scott United States 13 1.1k 1.5× 448 0.9× 109 0.4× 396 1.7× 68 0.5× 20 1.5k
Pranoot Tanpaiboon United States 18 329 0.4× 110 0.2× 183 0.7× 285 1.2× 38 0.3× 55 820
Simona Fecarotta Italy 17 299 0.4× 165 0.3× 144 0.5× 207 0.9× 15 0.1× 41 775
Mamta Muranjan India 15 149 0.2× 128 0.3× 73 0.3× 168 0.7× 54 0.4× 80 688
Yavuz Renda Türkiye 16 159 0.2× 173 0.3× 60 0.2× 215 0.9× 27 0.2× 45 786
Maurice D. Kogut United States 21 158 0.2× 147 0.3× 107 0.4× 325 1.4× 83 0.6× 51 1.2k
C Huber Austria 4 120 0.2× 200 0.4× 84 0.3× 225 0.9× 59 0.5× 5 1.0k
Néji Tebib Tunisia 14 164 0.2× 59 0.1× 89 0.3× 164 0.7× 33 0.3× 66 537
Kwang‐Jen Hsiao Taiwan 18 111 0.2× 109 0.2× 105 0.4× 478 2.0× 25 0.2× 43 1.1k

Countries citing papers authored by David Ketteridge

Since Specialization
Citations

This map shows the geographic impact of David Ketteridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ketteridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ketteridge more than expected).

Fields of papers citing papers by David Ketteridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ketteridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ketteridge. The network helps show where David Ketteridge may publish in the future.

Co-authorship network of co-authors of David Ketteridge

This figure shows the co-authorship network connecting the top 25 collaborators of David Ketteridge. A scholar is included among the top collaborators of David Ketteridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ketteridge. David Ketteridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fuller, Maria & David Ketteridge. (2021). Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting. JIMD Reports. 60(1). 10–14. 2 indexed citations
3.
Antoniou, Georgia, et al.. (2020). Screening for Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis. Journal of Child Neurology. 35(6). 410–417. 8 indexed citations
4.
Runolfsdottir, Hrafnhildur L., Tzu-Ling Lin, David S. Goldfarb, et al.. (2020). Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series. Urolithiasis. 48(4). 337–344. 3 indexed citations
5.
Williams, Nicole, et al.. (2019). Tarsal tunnel syndrome in the mucopolysaccharidoses: A case series and literature review. JIMD Reports. 46(1). 16–22. 2 indexed citations
6.
Bush, Douglas, Jill Lipsett, David Ketteridge, et al.. (2018). Neonatal Onset Interstitial Lung Disease as a Primary Presenting Manifestation of Mucopolysaccharidosis Type I. JIMD Reports. 43. 71–77. 10 indexed citations
7.
Mordaunt, Dylan, Liam McIntyre, Drago Bratkovic, et al.. (2015). Presentation of m.3243A>G (MT‐TL1; tRNALeu) variant with focal neurology in infancy. American Journal of Medical Genetics Part A. 167(11). 2697–2701. 3 indexed citations
8.
Giugliani, Roberto, Christina Lampe, Nathalie Guffon, et al.. (2014). Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux–Lamy syndrome)—10‐year follow‐up of patients who previously participated in an MPS VI survey study. American Journal of Medical Genetics Part A. 164(8). 1953–1964. 68 indexed citations
9.
Wedatilake, Yehani, Ruth M. Brown, Robert McFarland, et al.. (2013). SURF1 deficiency: a multi-centre natural history study. Orphanet Journal of Rare Diseases. 8(1). 96–96. 91 indexed citations
10.
Wood, Timothy C., Olaf A. Bodamer, Maira Graeff Burin, et al.. (2012). Expert recommendations for the laboratory diagnosis of MPS VI. Molecular Genetics and Metabolism. 106(1). 73–82. 33 indexed citations
11.
Decker, Celeste, Zi‐Fan Yu, Roberto Giugliani, et al.. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Pediatric Rehabilitation Medicine. 3(2). 89–100. 52 indexed citations
12.
Auclair, Dyane, et al.. (2010). An overview of intra-articular therapy for mucopolysaccharidosis VI. Journal of Pediatric Rehabilitation Medicine. 3(1). 3–6. 6 indexed citations
13.
Harmatz, Paul, Roberto Giugliani, Ida Vanessa Döederlein Schwartz, et al.. (2008). Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Molecular Genetics and Metabolism. 94(4). 469–475. 159 indexed citations
14.
Karageorgos, Litsa, Doug A. Brooks, A.C. Pollard, et al.. (2007). Mutational analysis of 105 mucopolysaccharidosis type VI patients. Human Mutation. 28(9). 897–903. 97 indexed citations
15.
Ryan, Monique M., Carolyn Ellaway, David Ketteridge, et al.. (2007). 610: Dietary L-tyrosine supplementation in nemaline myopathy. Journal of Clinical Neuroscience. 14(10). 1020–1020. 2 indexed citations
16.
Karageorgos, Litsa, Doug A. Brooks, Paul Harmatz, et al.. (2006). Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy. Molecular Genetics and Metabolism. 90(2). 164–170. 29 indexed citations
17.
Salomons, Gajja S., C. Jakobs, Lorna Pope, et al.. (2006). Clinical, enzymatic and molecular characterization of nine new patients with malonyl‐coenzyme A decarboxylase deficiency. Journal of Inherited Metabolic Disease. 30(1). 23–28. 34 indexed citations
18.
Swiedler, Stuart J., Michael Beck, Roberto Giugliani, et al.. (2005). Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). American Journal of Medical Genetics Part A. 134A(2). 144–150. 117 indexed citations
19.
Boros, C., et al.. (1996). Cannabis cookies: A cause of coma. Journal of Paediatrics and Child Health. 32(2). 194–195. 31 indexed citations
20.
Ketteridge, David. (1975). Differentiation of newly isolated strains of Trypanosoma (Schizotrypanum) cruzi by agglutination and precipitation reactions.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(3). 173–89. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maira Graeff Burin Breakdown of academic impact, for papers by C. Ronald Scott Breakdown of academic impact, for papers by Pranoot Tanpaiboon Breakdown of academic impact, for papers by Simona Fecarotta Breakdown of academic impact, for papers by Mamta Muranjan Breakdown of academic impact, for papers by Yavuz Renda Breakdown of academic impact, for papers by Maurice D. Kogut Breakdown of academic impact, for papers by C Huber Breakdown of academic impact, for papers by Néji Tebib Breakdown of academic impact, for papers by Kwang‐Jen Hsiao
Rankless by CCL
2026